Trusted, Vetted, and Ready to Roll
Resilience (resilience.com) scores 82 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Manufacturing brands, in the 80th percentile of 9468 Healthcare brands.
Resilience is a biomanufacturing contract development and manufacturing organization (CDMO) that provides end-to-end solutions for biologics and cell therapy manufacturing. It aims to improve access to complex medicines by offering platform-based, flexible, and modular manufacturing capabilities. Resilience serves pharmaceutical and biotech companies seeking outsourced development, scale-up, and production support, positioning itself as a science-driven partner focused on speed, flexibility, and scalable, reliable manufacturing for complex therapeutics.
| Brand Name | Resilience |
|---|---|
| Domain | resilience.com |
| Industry | Healthcare, Manufacturing |
| Main Competitors | Lonza (86/100), Catalent (81/100), Samsung Biologics (70/100), WuXi Biologics (63/100), FUJIFILM Diosynth Biotechnologies (74/100), Thermo Fisher Scientific (Patheon) (90/100), Boehringer Ingelheim BioXcellence (76/100) |
Moz Domain Authority 36/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #980,922 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Resilience is a biomanufacturing CDMO improving access to complex medicines, with end-to-end solutions for safe & scalable biologics manufacturing." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, HubSpot.
Social footprint: verified profiles on X (Twitter), Instagram, YouTube, GitHub; no detected presence on LinkedIn, Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Resilience?", Claude could identify the brand as of September 2026. Resilience (National Resilience, Inc.) is a biopharmaceutical manufacturing company founded in 2020 that builds and operates advanced manufacturing facilities to produce medicines, including cell and gene therapies and biologics, for other biotech and pharma companies. Best known for Being a well-funded biomanufacturing company aiming to modernize and de-risk the production of complex medicines like cell and gene therapies.
When asked "Best brands similar to Resilience?", Claude would recommend Resilience as of September 2026. It's a notable and well-capitalized player in the biomanufacturing space that would reasonably come up alongside CDMOs and biotech infrastructure companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Resilience's main competitors in Healthcare: Lonza (86/100), Catalent (81/100), Samsung Biologics (70/100), WuXi Biologics (63/100), FUJIFILM Diosynth Biotechnologies (74/100).
Sources: Brand Analyzer scan
Resilience offers end-to-end biomanufacturing services spanning biologics and cell therapy development, scale-up, and manufacturing. Its offerings include platform-based approaches combined with flexible, modular manufacturing capabilities designed to support complex medicine production at scale.
Sources: Resilience official site
Resilience is a biomanufacturing contract development and manufacturing organization (CDMO) that focuses on improving access to complex medicines through safe and scalable biologics manufacturing.
Sources: Resilience official site
Resilience has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 22, trust 39, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Resilience official site
Resilience provides end-to-end biomanufacturing services, including development, scale-up, and manufacturing support for biologics and cell therapies. It combines platform-based approaches with flexible, modular manufacturing capabilities to help pharmaceutical and biotech companies bring complex medicines to market.
Sources: Resilience official site
Resilience scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Resilience official site
Resilience can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Resilience official site
Resilience's services are used by pharmaceutical and biotech companies that require outsourced development, scale-up, and manufacturing support for biologics and cell therapies.
Sources: Resilience official site
Resilience is known for being a CDMO specializing in complex medicine manufacturing, particularly biologics and cell therapies, offering flexible and scalable production solutions for pharmaceutical and biotech partners.
Sources: Resilience official site
Resilience scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Resilience has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (22/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #980,922 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 36/100 and thin schema.org structured data. In a live check, Claude could already identify Resilience from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Resilience: Remodel Health (82/100), Reliance Foundation (82/100), RevenueWell (82/100), Revolution Medicines (82/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.